23andMe Bankruptcy: Customer Claims Deadline Approaching
Genetic testing giant 23andMe, currently in Chapter 11 bankruptcy, is notifying customers of potential claims. The deadline to file is July 14, 2025.
The company, along with 11 subsidiaries including Lemonaid Health and LPRXOne, filed for bankruptcy protection on March 23, 2025, in the Eastern District of Missouri. This follows 18 months of declining sales, executive departures, and a significant data breach affecting nearly 7 million users.
Data Breach Claims
The October 2023 data breach exposed sensitive personal information, including names, birth years, family relationships, ancestry data, and self-reported locations. Customers notified by 23andMe about compromised information between May and October 2023 can file a Cyber Security Incident Claim. This allows individuals who suffered financial or other damages due to the breach to seek compensation.
You can find more information on the Cyber Security Incident Claim form.
General Claims
Customers with grievances unrelated to the cyberattack, such as issues with DNA test results or telehealth services, can file a separate claim. This falls under the General Bar Date Package.
You can find more information on the General Bar Date Package form.
Bankruptcy and Related Issues
23andMe's bankruptcy has raised concerns in Congress regarding privacy implications. The company's rapid decline was exacerbated by costly expansions into digital health and telemedicine, including the 2021 acquisition of Lemonaid Health for $400 million. This strategy ultimately strained resources and failed to deliver expected growth.
A proposed $30 million settlement in a class action lawsuit related to the data breach is currently on hold due to the bankruptcy proceedings. 23andMe's attorneys state the settlement is now disputed. Regardless of participation in the class action, customers wishing to preserve their right to compensation must file a formal proof of claim.
